- Associated Press - Tuesday, July 22, 2014

FAYETTEVILLE, Ark. (AP) - Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that improve a patient’s immune response against tumors.

The goal of the five-year grant is to help clinicians attack hidden metastatic tumors and prevent cancer recurrence. Metastasis is the development of secondary malignancy away from the primary site of cancer.

David Zaharoff, an assistant professor of biomedical engineering and the principal investigator for the project, says metastasis - not a patient’s primary tumor - kills about 90 percent of cancer patients.


Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide